Literature DB >> 33288199

Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2.

Lin Xu1, Jiandong Gao1, Di Huang1, Pinglan Lin1, Dongsheng Yao1, Feng Yang1, Yaheng Zhang1, Xuejun Yang1, Ming Wu2, Chaoyang Ye3.   

Abstract

Emodin, a major component of Chinese herbal rhubarb, delays the progression of chronic renal failure. However, the effect and working mechanisms of Emodin on renal tubulointerstitial fibrosis remains elusive. We hypothesized that emodin inhibits renal tubulointerstitial fibrosis through EZH2, a histone methyltransferase. Our in vivo and in vitro studies demonstrate that emodin reduced extracellular collagen deposition and inhibited Smad3 and CTGF pro-fibrotic signaling pathways, which were correlated with the down-regulation of EZH2 and reduced trimethylation of histone H3 on lysine 27 (H3k27me3) in NRK-49F fibrotic cells and UUO kidneys. Inhibition of EZH2 by 3-DZNeP blocked or attenuated the anti-fibrotic effect of emodin in UUO kidneys and NRK-49F cells. These data indicate that emodin inhibits renal tubulointerstitial fibrosis in obstructed kidneys and this effect is mediated through EZH2.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emodin; Enhancer of zeste homolog 2; Renal fibrosis

Mesh:

Substances:

Year:  2020        PMID: 33288199     DOI: 10.1016/j.bbrc.2020.11.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.

Authors:  Xiao-Yuan Liu; Xu-Bin Zhang; Ya-Feng Zhao; Kai Qu; Xiao-Yong Yu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

Review 2.  Protein Methylation in Diabetic Kidney Disease.

Authors:  Ye Cheng; Yanna Chen; Guodong Wang; Pei Liu; Guiling Xie; Huan Jing; Hongtao Chen; Youlin Fan; Min Wang; Jun Zhou
Journal:  Front Med (Lausanne)       Date:  2022-05-12

3.  Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region.

Authors:  Zhuowang Ge; Chengye Yin; Yingze Li; Ding Tian; Yin Xiang; Qianhui Li; Yong Tang; Yachen Zhang
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

4.  Overexpression of miR-101 suppresses collagen synthesis by targeting EZH2 in hypertrophic scar fibroblasts.

Authors:  Jie Li; Yan Li; Yunchuan Wang; Xiang He; Jing Wang; Weixia Cai; Yanhui Jia; Dan Xiao; Jian Zhang; Ming Zhao; Kuo Shen; Zichao Li; Wenbin Jia; Kejia Wang; Yue Zhang; Linlin Su; Huayu Zhu; Dahai Hu
Journal:  Burns Trauma       Date:  2021-11-26

Review 5.  Emodin-Mediated Treatment of Acute Kidney Injury.

Authors:  Yu Liu; Mingquan Li; LaiKuan Teh; Liangbin Zhao; Naijing Ye; Ling Wu; Lihua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

Review 6.  Natural products: potential drugs for the treatment of renal fibrosis.

Authors:  Zijun Zhou; Yanheng Qiao; Yanru Zhao; Xin Chen; Jie Li; Hanqing Zhang; Qiumei Lan; Bo Yang
Journal:  Chin Med       Date:  2022-08-17       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.